Dr. Stegh, in collaboration with Dr. Mirkin, Director of the International Institute for Nanotechnology at Northwestern, is working to develop novel and potent nanotechnological agents for the treatment of malignant glioma. "Together with our industry partners, we aim to drive nanotechnology towards pharmaceutical opportunities and to improve the survival of patients with brain tumors," says Dr. Stegh.